Kurt Karst is speaking at ACI’s Summit on Life Sciences IP Due Diligence
Exploring the Regulatory Aspect of Life Sciences IP Due Diligence: Examining the Implications of Recent Developments at the FDA on DiligencingWhen
November 28-29, 2023Where
The WestinCopley Place
Boston, MA
Contact
For more information, see conference website
Related Professionals
- Kurt R. Karst
Director